Diethyl-(1-ethoxycarbonyl-propyl)-phosphinoxid | 95140-89-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Diethyl-(1-ethoxycarbonyl-propyl)-phosphinoxid
• 英文别名: ethyl 2-(diethylphosphoryl)-2-ethylacetate；ethyl 2-diethylphosphorylbutanoate
• CAS: 95140-89-9
• 化学式: C₁₀H₂₁O₃P
• 分子量: 220.249
• InChiKey: DAGAYULAAMQDSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Diethyl-(1-ethoxycarbonyl-propyl)-phosphinoxid 、 丙烯腈 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 生成 4-Cyano-2-(diethyl-phosphinoyl)-2-ethyl-butyric acid ethyl ester
  参考文献：
  名称：

  Razumov,A.I. et al., Journal of general chemistry of the USSR, 1969, vol. 39, p. 2186 - 2189

  摘要：

  DOI：
• 作为产物：
  描述：

  triethyl phosphonoacetate 、 碘乙烷 在 氢化钾 作用下， 以 甲苯 为溶剂， 生成 Diethyl-(1-ethoxycarbonyl-propyl)-phosphinoxid
  参考文献：
  名称：

  Razumov,A.I.; Zabusova,N.G., Journal of general chemistry of the USSR, 1962, vol. 32, # 8, p. 2646 - 2648

  摘要：

  DOI：

文献信息

• Chemo- and stereoselectivity in titanium-mediated regioselective ring-opening reaction of epoxides at the more substituted carbon
  作者：Tetsuaki Tanaka、Kei Hiramatsu、Yasutaka Kobayashi、Hiroaki Ohno

  DOI：10.1016/j.tet.2005.05.006

  日期：2005.7

  Chemo- and stereoselectivity in the ring-opening reaction of epoxides with a reagent prepared from allylmagnesium halide and chlorotitanium triphenoxide is described. It has been proven that the allylating reagent can also be used for the reaction of epoxides bearing a tert-butyl ester, amide, or acetal moiety, and that the epoxide cleavage regioselectively takes place at the more substituted carbon

  描述了环氧化物与由烯丙基卤化镁和三氧化氯钛制备的试剂在开环反应中的化学和立体选择性。已证明烯丙基化试剂也可用于带有叔丁酯，酰胺或乙缩醛部分的环氧化物的反应，并且在所有情况下，环氧化物的裂解均在更高取代的碳上进行。有趣的是，尽管无环2,2,3-三烷基环氧化物或3,3-二取代的2,3-环氧醇衍生物与烯丙基钛试剂的反应产生的烯丙基化产物几乎为1：1的非对映混合物，但其开环反应为2-取代的2,3-环氧醇衍生物立体定向地通过抗途径。后者反应对于季碳中心的不对称结构非常有用。
• Carboxylic acid derivatives and drugs containing the same
  申请人：Shinoda Masanobu

  公开号：US06884821B1

  公开（公告）日：2005-04-26

  Novel carboxylic acid derivatives of general formula (I), salts of the same, esters thereof, or hydrates of them, which are useful as insulin resistance improvers; and drugs containing the derivatives as the active ingredient. In said formula, R 1 is hydrogen, hydroxyl, alkyl, or the like; L is a single bond, a double bond, alkylene, or the like; M is a single bond, alkylene, or the like; T is a single bond, alkylene, or the like; W is carboxyl, —CON(R W1 )R W2 , or the like; represents a single or double bond; X is oxygen, alkenylene, or the like; Y is an aromatic hydrocarbon group which may contain a heteroatom, or the like; and Z is an aromatic hydrocarbon group which may contain a heteroatom.

  化合物的一般式（I）的新型羧酸衍生物，其盐、酯或水合物，可用作胰岛素抵抗改善剂；以及含有该衍生物作为活性成分的药物。在所述的公式中，R1是氢、羟基、烷基或类似物；L是单键、双键、烷基或类似物；M是单键、烷基或类似物；T是单键、烷基或类似物；W是羧基、—CON（RW1）RW2或类似物；表示单键或双键；X是氧、烯基烷基或类似物；Y是芳香族碳氢基团，可以包含杂原子或类似物；Z是芳香族碳氢基团，可以包含杂原子。
• CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME
  申请人：Eisai Co., Ltd.

  公开号：EP1216980A1

  公开（公告）日：2002-06-26

  The present invention provides a novel carboxylic acid compound, a salt thereof or a hydrate of them useful as an insulin-resistant improver, and a medicament comprising the compound as an active ingredient. That is, the present invention provides a carboxylic acid compound represented by the following formula (I), a salt thereof, an ester thereof or a hydrate of them. In the formula, R1 represents hydrogen atom, hydroxyl group or a C1-6 alkyl group etc. which may have one or more substituents; L represents a single or double bond or a C1-6 alkylene group etc. which may have one or more substituents; M represents a single bond or a C1-6 alkylene group etc. which may have one or more substituents; T represents a single bond or a C1-3 alkylene group which may have one or more substituents; W represents carboxyl group or a group represented by the formula -CON(Rw1)Rw2 (wherein Rw1 and Rw2 are the same as or different from each other and each represents hydrogen atom, formyl group etc.) etc.; represents a single or double bond; X represents oxygen atom or a C2-6 alkenylene group etc. which may have one or more substituents; Y represents a C5-12 aromatic hydrocarbon group etc. which may have one or more substituents and which may have one or more heteroatoms; and ring Z represents a C5-6 aromatic hydrocarbon group which may have 0 to 4 substituents and which may have one or more heteroatoms.

  本发明提供了一种新型羧酸化合物、其盐或它们的水合物，可用作胰岛素抗性改进剂，以及包含该化合物作为活性成分的药物。也就是说，本发明提供了由下式（I）代表的羧酸化合物、其盐、酯或它们的水合物。 式中，R1 代表氢原子、羟基或 C1-6 烷基等，可有一个或多个取代基；L 代表单键或双键或 C1-6 亚烷基等，可有一个或多个取代基；M 代表单键或 C1-6 亚烷基等，可有一个或多个取代基。W 代表羧基或由式-CON(Rw1)Rw2 所代表的基团（其中 Rw1 和 Rw2 彼此相同或不同，且各自代表氢原子、甲酰基等）等。)等表示的基团；代表单键或双键；X 代表氧原子或 C2-6 烯基等，可有一个或多个取代基；Y 代表 C5-12 芳烃基等，可有一个或多个取代基，可有一个或多个杂原子；环 Z 代表 C5-6 芳烃基，可有 0 至 4 个取代基，可有一个或多个杂原子。
• EP1216980
  申请人：——

  公开号：——

  公开（公告）日：——
• US6884821B1
  申请人：——

  公开号：US6884821B1

  公开（公告）日：2005-04-26